Independent Data Monitoring Committee IDMC/DSMB Challenges during COVID pandemic
Webinar - Free Q&A Session
|Date(s)||19 Oct. 2020|
|Day(s)||17:00 - 18:00|
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
If there are any concerns relating to IDMC/DSMB that you are aware of, these may be raised in this webinar using the Questions box or alternatively by sending them in beforehand. They will be raised during the Webinar but in a completely anonymous fashion with no reference to the person / organisation / facility where the issue arose.
Basic introduction to regulatory requirements for IDMC
Seif Eddine Amara Madi, GSK Biologicals
Common findings relating to IDMC/DSMB during audits and inspections
Louise Mawer, Mirabilitas Ltd
Main challenges for IDMC expert during COVID-19
Stephen Toovey, Pegasus Medical & Scientific Services
IDMCs/DSMBs: a short research ethics primer
Heather Sampson, University of Toronto
Main challenge for IDMC management a sponsor perspective
Q&A and Discussion
Moderator(s): Seif Eddine Amara Madi, GSK Biologicals
End of the Webinar